Daily Junction.mobi portalNews · September 12, 2024 · Daily Junction Editorial Team · 13 min
Drug-related deaths in England and Wales reached 5,448 in 2023, the highest number since records began in 1993. Opioids account for half of all deaths, with synthetic opioids and cocaine driving increases. Public health experts warn the UK faces an American-style opioid epidemic without urgent investment in treatment and harm reduction.
The United Kingdom is facing its worst drug death crisis on record. 5,448 people died from drug-related causes in England and Wales in 2023, an 11% increase from 2022 and the highest number since records began in 1993, according to data published by the Office for National Statistics (ONS) in September 2024. Opioids were involved in half of all deaths, with synthetic opioids like fentanyl and nitazenes—substances far more potent than heroin—driving much of the increase. Cocaine deaths have quadrupled since 2013, reaching 1,118 in 2023. Scotland's drug death rate remains the highest in Europe, at 277 deaths per million people, more than three times England's rate of 80 per million.
Public health experts warn that the UK is on the brink of an American-style opioid epidemic unless urgent action is taken. Treatment services have been cut by 30% in real terms since 2010, leaving only half of people with opioid dependence in treatment. Harm reduction measures proven to save lives—such as supervised consumption rooms and drug checking services—remain illegal or severely restricted. The government announced £532 million in additional funding in 2022, but the Advisory Council on the Misuse of Drugs estimates the UK needs an additional £1 billion per year to provide adequate treatment capacity and prevent further deaths.
The ONS data reveals the depth of the crisis:
These figures represent only deaths where drugs were the underlying cause (i.e., the primary reason for death). The true toll is higher when including deaths where drugs were a contributing factor but not the primary cause, which brings the total to over 7,000 deaths in 2023.
Opioids remain the deadliest class of drugs in the UK. In 2023:
A significant driver of opioid deaths is the ageing cohort of people who started using heroin in the 1980s and 1990s. Many are now in their 40s and 50s with deteriorating health from decades of drug use, homelessness, and inadequate healthcare. This group has high rates of hepatitis C, HIV, cardiovascular disease, and mental health conditions, making them particularly vulnerable to overdose.
Public Health England data shows that the average age of people in opioid treatment has risen from 32 in 2005 to 42 in 2023. Many have been in and out of treatment for decades, with multiple relapses. The system is failing to provide the long-term, wraparound support needed to keep this vulnerable group alive.
The emergence of synthetic opioids represents a dangerous escalation. Fentanyl, a pharmaceutical opioid 50-100 times more potent than heroin, has been detected in the UK drug supply with increasing frequency since 2016. It is often mixed into heroin or sold as counterfeit prescription pills (fake OxyContin, Xanax, or diazepam).
Even more alarming is the rise of nitazenes, a class of synthetic opioids developed in the 1950s but never approved for medical use. Nitazenes are 10-40 times more potent than fentanyl and up to 500 times stronger than heroin. First detected in the UK in 2021, they have been linked to at least 278 deaths by 2023, according to the National Crime Agency.
Nitazenes are particularly dangerous because:
The National Crime Agency has issued urgent warnings to drug users and health services, but the spread of nitazenes continues. In 2024, nitazene-related deaths are on track to exceed 400.
While opioids dominate headlines, cocaine deaths have surged with less public attention. In 2023, cocaine was involved in 1,118 deaths, a 400% increase since 2013. The rise is driven by:
Cocaine purity in the UK has increased from an average of 20-30% in the 2000s to 60-70% in 2024, according to drug testing data. Higher purity means users are consuming far more of the active drug than they expect, increasing the risk of cardiac arrest, stroke, and seizures.
Cocaine is also more available and cheaper than ever. The National Crime Agency reports that cocaine seizures have tripled since 2010, yet street prices have remained stable or fallen, indicating a saturated market.
Most cocaine deaths involve multiple substances. Common combinations include:
The rise in poly-drug use reflects the chaotic drug market, where users often consume multiple substances without knowing what they contain or how they interact.
Crack cocaine use is concentrated in deprived urban areas, particularly in London, Manchester, and the West Midlands. Crack is associated with homelessness, sex work, and violent crime, and users face severe stigma and barriers to treatment.
Public Health England data shows that crack users are far less likely to access treatment than powder cocaine users, and when they do, they face longer waiting times and fewer treatment options. Many services are not equipped to address the complex needs of crack users, who often have co-occurring mental health conditions, trauma, and housing instability.
Scotland's drug death crisis is even more severe than England and Wales. In 2023, 1,051 people died from drug-related causes in Scotland, a rate of 277 per million people—the highest in Europe and more than three times England's rate.
The reasons for Scotland's exceptionally high death rate are debated, but key factors include:
The Scottish Government has declared drug deaths a public health emergency and committed to expanding treatment capacity, but progress has been slow. A pilot safer drug consumption facility in Glasgow has been approved in principle but faces legal and political obstacles.
A major driver of rising drug deaths is the collapse of treatment services since 2010. Public Health England data shows:
The cuts have been particularly severe in deprived areas with the highest need. A 2024 report by the Advisory Council on the Misuse of Drugs found that areas with the highest drug death rates had seen the largest cuts to treatment funding.
The government announced £532 million over three years in 2022 to rebuild treatment capacity, but experts say this is insufficient to reverse a decade of cuts. The Advisory Council estimates the UK needs an additional £1 billion per year to provide adequate treatment capacity, including:
The UK's approach to drug policy has historically emphasised abstinence-based treatment over harm reduction. While treatment is essential, harm reduction measures proven to save lives remain illegal or severely restricted:
Supervised consumption rooms (also called drug consumption rooms or safer injecting facilities) are spaces where people can use drugs under medical supervision, with sterile equipment and immediate access to overdose reversal. They have been shown to:
![[View image]](/img/uk-drug-deaths-record-high-2024.jpg){kind=link}